DT Investment Partners’s Quest Diagnostics DGX Stock Holding History

DT Investment Partners’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$27.8K	Hold	131	–	–	﹤0.01%	301
2026 Q1	$25.7K	Hold	131	–	–	﹤0.01%	304
2025 Q4	$22.7K	Hold	131	–	–	﹤0.01%	322
2025 Q3	$25K	Hold	131	–	–	﹤0.01%	305
2025 Q2	$23.5K	Hold	131	–	–	﹤0.01%	301
2025 Q1	$22.2K	Hold	131	–	–	﹤0.01%	306
2024 Q4	$19.8K	Hold	131	–	–	﹤0.01%	322
2024 Q3	$20.3K	Buy	131 +41	+46%	+$6.12K	﹤0.01%	353
2024 Q2	$12.3K	Hold	90	–	–	﹤0.01%	363
2024 Q1	$12K	Hold	90	–	–	﹤0.01%	329
2023 Q4	$11.6K	Hold	90	–	–	﹤0.01%	326
2023 Q3	$11K	Hold	90	–	–	﹤0.01%	308
2023 Q2	$12.1K	Hold	90	–	–	﹤0.01%	306
2023 Q1	$12.6K	Hold	90	–	–	﹤0.01%	301
2022 Q4	$14.1K	Hold	90	–	–	﹤0.01%	294
2022 Q3	$11K	Buy	+90	New	+$11.9K	﹤0.01%	292

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

DT Investment Partners's DGX Position: Q2 2026 in Review

DT Investment Partners held its Quest Diagnostics (DGX) position steady in Q2 2026 at 131 shares worth $27.8K. The position accounts for ﹤0.01% of the portfolio, ranked #301.

DT Investment Partners first reported a position in DGX in Q3 2022 and has held it in 16 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

DT Investment Partners held 131 shares of Quest Diagnostics worth $27.8K as of Q2 2026.
DT Investment Partners left its Quest Diagnostics share count unchanged in Q2 2026.
Quest Diagnostics made up ﹤0.01% of DT Investment Partners's portfolio in Q2 2026, its #301 holding.
DT Investment Partners first reported a position in Quest Diagnostics in Q3 2022 and has held it in 16 quarters since.
1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on DT Investment Partners's 13F filing for Q2 2026, filed 27 Jul 2026.